Trump Rescinds Biden Policy Requiring Hospitals to Provide Emergency Abortions
The Trump administration announced on Tuesday that it had revoked a Biden administration requirement that hospitals provide emergency abortions to women whose health is in peril, including in states where abortion is restricted or banned.
The move by the Centers for Medicare and Medicaid Services, a branch of the department led by Health Secretary Robert F. Kennedy Jr., was not a surprise. But it added to growing confusion around emergency care and abortions since June 2022, when the Supreme Court rescinded the national right to abortion by overturning Roe v. Wade.
'It basically gives a bright green light to hospitals in red states to turn away pregnant women who are in peril,' Lawrence O. Gostin, a health law expert at Georgetown University, said of the Trump administration's move.
The administration did not explicitly tell hospitals that they were free to turn away women seeking abortions in medical emergencies. Its policy statement said hospitals would still be subject to a federal law requiring them to provide reproductive health care in emergency situations. But it did not explain exactly what that meant.
Mr. Gostin and other experts said the murky policy could have dire consequences for pregnant women by discouraging doctors from performing emergency abortions in states where abortions are banned or restricted.
'We've already seen since the overturn of Roe that uncertainty and confusion tends to mean physicians are unwilling to intervene, and the more unwilling physicians are to intervene, the more risk there is in pregnancy,' said Mary Ziegler, a professor at the University of California-Davis and a historian of the American abortion debate.
Want all of The Times? Subscribe.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
Mahmoud Khalil ordered released by federal judge
A federal judge is ordering the release of Columbia University pro-Palestinian activist Mahmoud Khalil. U.S. District Judge Michael Farbiarz indicated that he will issue an order requiring that Khalil be released today. He denied a motion by the government to stay the ruling for seven days. MORE: Judge denies Palestinian activist Mahmoud Khalil's request for release The judge asked the parties to consult with a magistrate judge about any conditions that will be attached to Khalil's release on bail. Last week, Judge Farbiarz issued a preliminary injunction barring the Trump administration from continuing to detain Khalil based on Secretary of State Marco Rubio's determination that his continued presence in the country would pose a risk to foreign policy -- but the judge subsequently sided with the government in ruling that Khalil could continue to be detained on the grounds that he misrepresented information on his green card application. Khalil, a green card holder who is married to an American citizen, has been held in a detention facility since he was arrested by ICE agents in New York City in March. This is a developing story. Please check back for updates.
Yahoo
29 minutes ago
- Yahoo
NY Daily News calls Adams' ban of City Hall reporter unconstitutional, demands reversal
NEW YORK — New York Daily News management is demanding that Mayor Eric Adams reverse his stated ban on the paper's senior City Hall reporter from mayoral press conferences, calling the move a violation of the Daily News' constitutional rights. An attorney for the paper made the demand in a letter sent to the city's Law Department Friday. 'Banning (senior City Hall reporter Chris) Sommerfeldt from attending the Mayor's press conferences is plainly unconstitutional,' attorney Matthew Leish wrote, citing both First and 14th amendment issues. Leish asked the Adams administration to drop the ban by noon on Monday at the latest, and did not rule out further legal action. '(T)he Daily News and Mr. Sommerfeldt expressly reserve all of their rights and remedies,' he wrote. As previously reported by the Daily News, Adams banned Sommerfeldt from future press conferences Tuesday after the reporter asked a question without raising his hand. Sommerfeldt has not been called on by the mayor's press staff in more than three months. The reporter had just asked a follow-up to another journalist's question when Adams said: 'You're calling out a lot, Chris, stop calling out!' the mayor said in a sing-song tone. 'You must have done that in school.' 'Listen, if he does that again, he's not to come into our conferences,' Adams then said to his press staff. Sommerfeldt then asked the mayor, 'You want to take a question from me, then?' 'He did it again,' Adams replied. 'Make sure security knows he's not allowed back into this room.' In his letter Friday, Leish, the Daily News' attorney, said the purported ban 'unquestionably violates the First Amendment,' which prohibits selective regulation of the press. 'The Mayor's press conferences are generally open to any credentialed journalist, and the purported reason for Mr. Sommerfeldt's exclusion – the fact that he asked questions without being called on – is completely arbitrary given that other journalists have done exactly the same thing without incident,' Leish wrote. The attorney said the ban also violated Sommerfeldt's 14th Amendment right to due process to address the proposed ban. Asked during a round table on the upcoming mayoral primary on WPIX Thursday about his plans, Sommerfeldt said he was going to continue 'doing my job.' Adams, asked if he planned to enforce the ban during a News 12 interview, said he expected there would be conversations between his team and Daily News management and that 'we'll decide what we're going to do from there.' City hall did not immediately respond to a request for comment. The letter comes amid a groundswell of opposition to the ban. The New York Press Club, the Freedom of the Press Foundation and PEN America have all called on Adams to drop the ban, as has the Daily News Union. Republican mayoral hopeful Curtis Sliwa and Democratic candidate Zellnor Myrie also criticized Adams for the ban. _____
Yahoo
38 minutes ago
- Yahoo
Penumbra may gain market share in peripheral embolisation coils with Ruby XL
Penumbra has announced US Food and Drug Administration approval for its Ruby XL system, which includes three coils: the Ruby XL, the POD XL and the Packing Coil XL. The Ruby XL coil is a device used in vascular embolisation, a procedure to block or close off blood vessels, and can be used to frame large aneurysms, while the POD XL is designed for use in high-flow vessels and the Packing Coil XL is designed to adjust to the shape of any vessel up to 70cm in length. All Ruby XL system coils can be delivered through a 0.035-inch diagnostic catheter. The system is expected to enable Penumbra to increase its market share in peripheral embolisation coils, according to leading data and analytics company GlobalData. According to GlobalData's US healthcare facility invoicing database, Penumbra currently holds the majority market share for peripheral embolisation coils. Its new coil system allows for peripheral embolisation procedures to be done on a wider range of aneurysm sizes and in longer vessels. If the Ruby XL coil is widely adopted by physicians, Penumbra may be able to capture half the entire market. The approval of the new coil could put a bigger gap between Penumbra and its competitors in the market. Physicians may choose Ruby XL coils for their procedures in order to gain better control of large aneurysms. The Ruby XL system may come with cost savings for consumers as it delivers more volume per coil than other available coils. The average selling price (ASP) of these coils ranges from approximately $900 to $2,000. Already in the middle of this range with its current coils, Penumbra has a competitive advantage for new products. If they come in with a competitive ASP, Penumbra may displace competitor coils for relevant procedures. Penumbra stands to maintain its market lead and possibly increase its market share as the purchasing of the Ruby XL system begins. GlobalData will continue to monitor market trends as purchasing picks up. It is expected that facilities will begin purchasing these coils in June 2025. "Penumbra may gain market share in peripheral embolisation coils with Ruby XL" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
